Skip to main content
. 2020 Apr 25;6(4):e03600. doi: 10.1016/j.heliyon.2020.e03600

Table 1.

Characteristics of 97 HIV-infected patients' sample.

Mean age (years, SD) 15 (4.51)
5–16 years (%, n) 60% (58)
17–23 years (%, n) 40% (39)

Sociodemographic characteristics (%, n)

Female Gender 66% (64)

Ethnicity

 Caucasian 64% (62)
 Sub Saharan Africa 11% (11)
 South America 8% (8)
 Other 17% (16)

Family structure

 Biologic parent/s 49% (47)
 Grandparents or extended family 16% (15)
 Foster care or adoption 29% (28)
 Other 7% (7)

Parental education (most educated caregiver)

 No education/Read and write 17% (16)
 Elementary/Secondary school 31% (30)
 High school or higher degrees 47% (46)
 Unknown 5% (5)

Attending at school 85% (82)

Number of repeated grades

 0 27% (26)
 1 28% (27)
 ≥2 35% (34)
 No data 10% (10)

Reported academic performance

 Good 29% (28)
 Poor 41% (40)
 With difficulties 20% (19)
 No data 10% (10)

Immunological and virological characteristics at study entry

AIDS (%, n) 27% (26)
HIV-Encephalopathy (%, n) 10% (10)
Hepatitis C virus (%, n) 6% (6)
Median CD4 cells/mm3 (IQR) 770 (570, 1004)
Median CD4 % (IQR) 35 (30, 40)
Median CD4/CD8 (IQR) 1.00 (0.7, 1.40)
Viral load <50 cop/ml (%, n) 80% (78)
Median Nadir CD4 cells/mm3 (IQR) 360 (185, 463)
Median Nadir CD4 % (IQR) 15% (10, 22)
Median age at diagnosis (IQR) 0.46 (0, 12.24)
Antiretroviral treatment (years, IQR)
Median age at the start of ART (IQR) 1.34 (0.01, 14)
Median age at the start of cART (IQR) 2.62 (0.01, 15)
Time of treatment with ART (IQR) 12.45 (0.98, 21)
Time of treatment with cART (IQR) 11.10 (0.51, 17)
Median number of cART regimens (IQR) 4 (0, 12)

Current treatment situation (%, n)

Patients without ART 6% (6)
Patients with cART 89% (86)
Good adherence to treatment 86% (78)

Abbreviations: SD: Standard Deviation, AIDS: Acquired Immune Deficiency Syndrome, HIV: Human Immunodeficiency Virus, CD4: CD4 T lymphocytes, IQR: Interquartile range, ART: Antiretroviral therapy, cART: Combination Antiretroviral Therapy.